ENTX Entera Bio Ltd

Entera Bio Ltd is a biotechnology company specializing in the oral delivery of large molecules and biologics. It conducts clinical trials on its proprietary technology which allows oral delivery of large molecules and biologics.

As of 06/30/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  06/29/2018
Outstanding shares:  28,809,923
Average volume:  40,318
Market cap:   $38,605,297
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -5.95
PB ratio:   1.96
PS ratio:   253.18
Return on equity:   109.77%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy